T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 4, 2012

NCT03022435 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: TIV
BIOLOGICAL: High-Dose TIV
BIOLOGICAL: LAIV

Sponsor

Stanford University

Collaborators

[object Object]